AI Verdict
AMZN has stronger fundamentals based on our AI analysis.
IMRX vs AMZN Fundamental Comparison
| Metric | IMRX | AMZN |
|---|---|---|
| Revenue | $0.0 | $716.9B |
| Net Income | $-56.0M | $77.7B |
| Net Margin | N/A | 10.8% |
| ROE | -25.6% | 18.9% |
| ROA | -24.2% | 9.5% |
| Current Ratio | 17.50x | 1.05x |
| Debt/Equity | 0.00x | 0.17x |
| EPS | $-1.27 | $7.17 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMRX vs AMZN: Frequently Asked Questions
Is IMRX or AMZN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMZN has stronger fundamentals. IMRX is rated SELL (72% confidence) while AMZN is rated BUY (81% confidence). This is not investment advice.
How does IMRX compare to AMZN fundamentally?
Immuneering Corp has ROE of -25.6% vs AMAZON COM INC's 18.9%. Net margins are N/A vs 10.8% respectively.
Which stock pays higher dividends, IMRX or AMZN?
IMRX has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMRX or AMZN for long term?
For long-term investing, consider that IMRX has SELL rating with 72% confidence, while AMZN has BUY rating with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMRX vs AMZN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMRX vs AMZN, the AI consensus favors AMZN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.